JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
THS
3201
DELISTED
Treehouse Foods
THS
| $3.77M | ﹤0.01% |
91,018
-14,037
| -13% | -$576K |
2013 Q2
42 quarters
|
|
3202
RadNet
RDNT
$5.5B
| $3.77M | ﹤0.01% |
108,417
+8,905
| +9% | +$281K |
2016 Q4
28 quarters
|
|
3203
PUT
Bath & Body Works
BBWI
$3.24B
| $3.76M | ﹤0.01% |
87,200
+69,400
| +390% | +$2.34M |
2021 Q1
11 quarters
|
|
3204
Lindsay Corp
LNN
$1.16B
| $3.76M | ﹤0.01% |
29,136
-990
| -3% | -$121K |
2013 Q2
42 quarters
|
|
3205
ProShares S&P 500 ex-Energy ETF
SPXE
$86.9M
| $3.76M | ﹤0.01% |
73,898
+12,772
| +21% | +$608K |
2023 Q1
3 quarters
|
|
3206
State Street SPDR S&P Semiconductor ETF
XSD
$3.25B
| $3.76M | ﹤0.01% |
16,713
-2,348
| -12% | -$461K |
2015 Q1
35 quarters
|
|
3207
Recursion Pharmaceuticals
RXRX
$2.21B
| $3.75M | ﹤0.01% |
380,810
-574,089
| -60% | -$4.09M |
2021 Q2
10 quarters
|
|
|
KAMN
3208
DELISTED
Kaman Corp
KAMN
| $3.75M | ﹤0.01% |
156,586
-32,965
| -17% | -$682K |
2015 Q4
32 quarters
|
|
3209
ADT
ADT
$4.57B
| $3.75M | ﹤0.01% |
549,740
+3,375
| +0.6% | +$21K |
2018 Q1
23 quarters
|
|
|
GPP
3210
DELISTED
Green Plains Partners LP
GPP
| $3.75M | ﹤0.01% |
294,471
-79,625
| -21% | -$1.06M |
2018 Q1
23 quarters
|
|
3211
Turning Point Brands
TPB
$1.12B
| $3.74M | ﹤0.01% |
142,232
+138
| +0.1% | +$3.16K |
2017 Q4
24 quarters
|
|
3212
Agilysys
AGYS
$2.8B
| $3.74M | ﹤0.01% |
44,111
+6,307
| +17% | +$512K |
2015 Q4
32 quarters
|
|
|
ZUO
3213
DELISTED
Zuora, Inc.
ZUO
| $3.72M | ﹤0.01% |
396,157
+68,930
| +21% | +$569K |
2018 Q2
22 quarters
|
|
3214
Vital Farms
VITL
$389M
| $3.72M | ﹤0.01% |
236,889
+18,949
| +9% | +$240K |
2020 Q3
13 quarters
|
|
3215
Mitek Systems
MITK
$801M
| $3.72M | ﹤0.01% |
285,000
+115,121
| +68% | +$1.28M |
2017 Q3
25 quarters
|
|
3216
PUT
Digital Realty Trust
DLR
$66.2B
| $3.71M | ﹤0.01% |
27,600
+11,600
| +73% | +$1.5M |
2023 Q3
1 quarter
|
|
|
XRN
3217
Chiron Real Estate Inc
XRN
$450M
| $3.71M | ﹤0.01% |
66,923
-1,137
| -2% | -$55.1K |
2017 Q4
24 quarters
|
|
3218
CALL
Humana
HUM
$46.6B
| $3.71M | ﹤0.01% |
8,100
-9,200
| -53% | -$4.53M |
2021 Q2
10 quarters
|
|
|
EFC
3219
Ellington Financial
EFC
$1.49B
| $3.7M | ﹤0.01% |
291,260
+113,299
| +64% | +$1.44M |
2018 Q4
20 quarters
|
|
|
APLS
3220
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| $3.7M | ﹤0.01% |
61,800
-494,500
| -89% | -$25.1M |
2022 Q3
5 quarters
|
|
3221
Viper Energy
VNOM
$7.9B
| $3.7M | ﹤0.01% |
117,800
-47,488
| -29% | -$1.41M |
2016 Q2
30 quarters
|
|
|
AAMI
3222
Acadian Asset Management
AAMI
$3.34B
| $3.7M | ﹤0.01% |
192,872
+33,078
| +21% | +$584K |
2016 Q4
28 quarters
|
|
3223
Dorman Products
DORM
$3.65B
| $3.69M | ﹤0.01% |
44,203
-4,961
| -10% | -$371K |
2015 Q4
32 quarters
|
|
3224
SI-BONE Inc
SIBN
$810M
| $3.68M | ﹤0.01% |
175,460
-95,353
| -35% | -$1.76M |
2018 Q4
20 quarters
|
|
3225
NBT Bancorp
NBTB
$2.68B
| $3.68M | ﹤0.01% |
87,872
-5,926
| -6% | -$214K |
2013 Q2
42 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.